Welcome to our dedicated page for INTERNATIONAL FLAVORS & FRAGRANCES SEC filings (Ticker: IFF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
International Flavors & Fragrances Inc. filings document a public specialty-ingredients company with common stock and debt securities, including senior notes, and formal disclosures for operating results, material events and capital structure. Recent 8-K reports furnish quarterly and annual financial results and record other material corporate actions.
Proxy and annual-meeting filings cover board elections, auditor ratification, advisory executive-compensation votes and shareholder voting results. Other filings address amended bylaws, indemnification provisions, officer and accounting-leadership changes, material agreements, governance matters and portfolio actions, including completed divestitures described in company proxy materials.
International Flavors & Fragrances (IFF) filed a Form 4 reporting open‑market stock purchases by a director. On 11/06/2025, 1,500 shares were acquired at $62.905, bringing direct holdings to 9,196 shares. On 11/07/2025, 5,250 shares were acquired at a weighted average price of $62.4633 (purchases ranged from $62.25 to $62.62), increasing direct holdings to 14,446 shares. Also on 11/07/2025, 2,000 shares were acquired at $62.09, held indirectly by the director’s spouse, with 8,500 shares held indirectly after the transaction.
IFF filed a Form 144 notice for a proposed sale of 4,060 common shares. The filing lists an aggregate market value of $253,809.54, with an approximate sale date of 11/07/2025 on the NYSE through Fidelity Brokerage Services LLC. The seller’s shares were acquired via restricted stock vesting on multiple dates from 10/03/2023 through 11/01/2025. Shares outstanding were 256,096,379.
International Flavors & Fragrances (IFF) reported Q3 2025 results showing softer sales but positive net income. Net sales were $2,694 million versus $2,925 million a year ago, and net income attributable to shareholders was $40 million (diluted EPS $0.16) versus $58 million ($0.23). Adjusted Operating EBITDA was $519 million versus $568 million.
Year‑to‑date, IFF posted a net loss of $392 million driven by a $1,153 million goodwill impairment and a $108 million loss on assets held for sale, partially offset by a $488 million gain on extinguishment of debt. Cash from operations reached $532 million, aided by divestiture activity: the Pharma Solutions sale closed for $2,564 million cash (fair value consideration $2,651 million including a $100 million earnout estimate), the Nitrocellulose sale brought $161 million, and a Tobacco Flavoring business sale yielded $20 million.
The balance sheet strengthened: cash was $621 million and long‑term debt fell to $4,741 million from $7,564 million. IFF recorded a $108 million impairment for the Soy Crush, Concentrates & Lecithin business now held for sale, with closing expected by the second quarter of 2026. The Board also authorized a $500 million share repurchase program.
International Flavors & Fragrances (IFF) furnished a press release reporting financial results for the quarter ended September 30, 2025. The company will host a live webcast to discuss third quarter 2025 results on November 5, 2025 at 9:00 a.m. ET, with access via ir.iff.com. A recording will be posted about one hour after the event and remain available for one year. The press release was furnished as an exhibit and is not deemed filed under the Exchange Act.
International Flavors & Fragrances (IFF) reported an insider equity award on Form 4. A company Director acquired 1,712 Restricted Stock Units (RSUs) on 11/03/2025.
The RSUs convert to Common Stock on a one‑for‑one basis and carry an exercise price of $0.0000. According to the filing, these RSUs will vest on May 1, 2026. Following the transaction, 1,712 derivative securities are shown as beneficially owned with direct (D) ownership.
International Flavors & Fragrances (IFF) reported an insider equity change: a company director acquired 1,712 restricted stock units (RSUs) on 11/03/2025, as disclosed on Form 4. The filing lists the RSU transaction at $0.0000.
The RSUs convert to Common Stock on a one-for-one basis and are scheduled to vest on May 1, 2026. Following the reported transaction, the filing shows 1,712 derivative securities beneficially owned with direct ownership.
International Flavors & Fragrances Inc. updated its corporate bylaws. On October 29, 2025, the company’s Board of Directors approved and adopted amended and restated bylaws, which became effective immediately. These bylaws govern how the company is managed and how its Board and shareholders operate.
The report explains that only a summary of the changes is provided and that the full details are contained in the complete text of the amended and restated bylaws, which are filed as an exhibit to the report. Investors and stakeholders who want to understand the exact governance changes can review the bylaws in the attached exhibit.
International Flavors & Fragrances (IFF) disclosed an initial beneficial ownership statement on Form 3 for a reporting person serving as a Director. The filing, tied to an event date of 10/20/2025, states that no securities are beneficially owned.
The submission was filed by one reporting person under Section 16, indicating a baseline disclosure of holdings upon becoming a director.
International Flavors & Fragrances (IFF) reported an insider status change. A Director filed a Form 3 initial statement of beneficial ownership for an event dated 10/20/2025. The filing states that no securities are beneficially owned. The form was filed by one reporting person.
International Flavors & Fragrances (IFF) announced Board changes pursuant to its Cooperation Agreement with the Icahn Group. On October 20, 2025, Brett Icahn and Dr. Richard Mulligan were appointed to the Board, effective immediately, following the departures of Vincent Intrieri and Margarita Paláu-Hernández.
Mr. Icahn joined the Audit Committee and Transaction Committee, while Dr. Mulligan joined the Innovation Committee. The company stated both departing directors left without any disagreement with IFF, management, or the Board. The Board determined that Mr. Icahn and Dr. Mulligan qualify as independent directors under NYSE rules. Both will participate in the non-employee director compensation arrangements described in IFF’s 2024 Proxy Statement.